Murilo de Almeida Luz, Alberto Briganti, Declan Murphy, Christopher Michael Pieczonka, Hiroyoshi Suzuki, Evan Y. Yu, Xavier Artignan, Geoffrey Gotto, Joelle Hamilton, Ryan J. Malone, Patrick Adorjan, Mercedeh Ghadessi, Frank Verholen, Andrew J. Armstrong. "Real-world darolutamide safety and effectiveness in nonmetastatic castration-resistant prostate cancer (nmCRPC) by lipid-modifying agent use: Post hoc analyses of DAROL interim analysis 4 (IA4).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.99